Altered liver function in patients undergoing veno-arterial extracorporeal membrane oxygenation therapy

Aaron Blandino Ortíz; Irene Lamanna; Elio Antonucci; Selene Pozzebon; Antonio Maria Dell’Anna; Jean Louis Vincent; Daniel De Backer; Fabio Silvio Taccone

doi:10.23736/s0375-9393.16.11442-7

Related publications

Article2016

The Impact of Renal Failure and Renal Replacement Therapy on Outcome During Extracorporeal Membrane Oxygenation Therapy

Elio Antonucci, Irene Lamanna, David Fagnoul, Jean Louis Vincent, Daniel De Backer, Fabio Silvio Taccone

Article2020

Electroencephalographic features in patients undergoing extracorporeal membrane oxygenation

Lorenzo Peluso, Serena Rechichi, Federico Franchi, Selene Pozzebon, Sabino Scolletta, Alexandre Brasseur, Benjamin Legros, Jean Louis Vincent, Jacques Créteur, Nicolas Gaspard, Fabio Silvio Taccone

Article2025

Real-world outcomes of venoarterial extracorporeal membrane oxygenation in cardiogenic shock patients related to acute myocardial infarction: a single-center experience

Jae Il Shin, Elise Kang, Seon Hwa Lee, Moonseong Heo, Yong‐Jae Lee, S J Lee, Soon Jun Hong, Jong Soo Kim, B K Kim, Young‐Guk Ko, Dong‐Ju Choi, Myeong‐Ki Hong, Yangsoo Jang, Cheol Min Ahn

Article2014

Vancomycin population pharmacokinetics during extracorporeal membrane oxygenation therapy: a matched cohort study

Katia Donadello, Jason A. Roberts, Stefano Cristallini, Marjorie Beumier, Kiran Shekar, Frédérique Jacobs, Asmae Belhaj, Jean Louis Vincent, Daniel De Backer, Fabio Silvio Taccone

Article2013

Meropenem and piperacillin pharmacokinetics during extracorporeal membrane oxygenation: A case-control study

Elio Antonucci, Katia Donadello, Stefano Cristallini, Marjorie Beumier, Frédérique Jacobs, Frédéric Cotton, Jean Louis Vincent, Fabio Taccone